Protecting active ingredients which are sensitive to the active environment of the stomach can be difficult. Capsugel® created the Capsugel® DRcaps® capsules as an acid-resistant alternative that provides protection. To clinically assess the efficacy of DRcaps® capsules for resistance to stomach acids for delayed delivery properties of ingredients, a human clinical study was designed to evaluate the disintegration behavior of unbanded DRcaps® capsules in human subjects. The study documents through images and data the success of unbanded DRcaps® capsules’ resistance to stomach acids for delivery of ingredients.
Please note that Lonza has updated its Privacy Policy. By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy Policy.
We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. Please read our updated Cookies Policy for information about which cookies we use and the information we collect. By continuing to use this website, you agree that we may store and access cookies on your device.
By clicking "I Agree", you confirm that you are above the age of 16, that you have read and understood the Privacy Policy and the Cookies Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policies.
If you have any questions, our experts are here to help.
Access all of the latest news, white papers, webinars and knowledge center resources.